Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study.

Ang J, Hajarizadeh B, Tillakeratne S, Dore GJ, Treloar C, Amin J, van Dyk J, Degenhardt L, Applegate T, Dunlop A, Fraser C, Conway B, Wong A, Fuchs D, Powis J, Mason K, Gane EJ, Weltman M, Read P, Martinello M, Rowe E, Baker DA, Wade A, Matthews G, Lafferty L, Lloyd A, Grebely J, Cunningham EB

Open source

DOI: 10.1016/j.drugpo.2025.104859
Published: 2025 Sep
Container: The International journal on drug policy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.drugpo.2025.104859,
  title = {Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study.},
  author = {Ang J and Hajarizadeh B and Tillakeratne S and Dore GJ and Treloar C and Amin J and van Dyk J and Degenhardt L and Applegate T and Dunlop A and Fraser C and Conway B and Wong A and Fuchs D and Powis J and Mason K and Gane EJ and Weltman M and Read P and Martinello M and Rowe E and Baker DA and Wade A and Matthews G and Lafferty L and Lloyd A and Grebely J and Cunningham EB},
  year = {2025},
  journal = {The International journal on drug policy},
  doi = {10.1016/j.drugpo.2025.104859},
  url = {https://doi.org/10.1016/j.drugpo.2025.104859}
}

RIS

TY  - JOUR
TI  - Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study.
AU  - Ang J
AU  - Hajarizadeh B
AU  - Tillakeratne S
AU  - Dore GJ
AU  - Treloar C
AU  - Amin J
AU  - van Dyk J
AU  - Degenhardt L
AU  - Applegate T
AU  - Dunlop A
AU  - Fraser C
AU  - Conway B
AU  - Wong A
AU  - Fuchs D
AU  - Powis J
AU  - Mason K
AU  - Gane EJ
AU  - Weltman M
AU  - Read P
AU  - Martinello M
AU  - Rowe E
AU  - Baker DA
AU  - Wade A
AU  - Matthews G
AU  - Lafferty L
AU  - Lloyd A
AU  - Grebely J
AU  - Cunningham EB
PY  - 2025
JO  - The International journal on drug policy
DO  - 10.1016/j.drugpo.2025.104859
UR  - https://doi.org/10.1016/j.drugpo.2025.104859
ER  -

APA

J, A., B, H., S, T., GJ, D., C, T., J, A., J, V. D., L, D., T, A., A, D., C, F., B, C., A, W., D, F., J, P., K, M., EJ, G., M, W., P, R., M, M., E, R., DA, B., A, W., G, M., L, L., A, L., J, G., & EB, C. (2025). Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study.. The International journal on drug policy. https://doi.org/10.1016/j.drugpo.2025.104859

Source records

pubmed · retrieved 2026-09-26T20:08:26.315Z